These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17363609)

  • 1. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic poliovirus therapy and immunization with poliovirus-infected cell lysate induces potent antitumor immunity against neuroblastoma in vivo.
    Toyoda H; Wimmer E; Cello J
    Int J Oncol; 2011 Jan; 38(1):81-7. PubMed ID: 21109928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
    J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.
    Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Nakamura T; Matsubara T; Asanuma K; Komada Y; Uchida A; Sudo A
    Int J Oncol; 2012 Sep; 41(3):893-902. PubMed ID: 22692919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
    Freistadt MS; Eberle KE
    Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection.
    Iwasaki A; Welker R; Mueller S; Linehan M; Nomoto A; Wimmer E
    J Infect Dis; 2002 Sep; 186(5):585-92. PubMed ID: 12195344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental treatment of human neuroblastoma using live-attenuated poliovirus.
    Toyoda H; Ido M; Hayashi T; Gabazza EC; Suzuki K; Kisenge RR; Kang J; Hori H; Komada Y
    Int J Oncol; 2004 Jan; 24(1):49-58. PubMed ID: 14654940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
    Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
    Fukuhara H; Ino Y; Kuroda T; Martuza RL; Todo T
    Cancer Res; 2005 Dec; 65(23):10663-8. PubMed ID: 16322208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.
    Li H; Dutuor A; Tao L; Fu X; Zhang X
    Clin Cancer Res; 2007 Jan; 13(1):316-22. PubMed ID: 17200370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
    Cello J; Paul AV; Wimmer E
    Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis.
    Gromeier M; Solecki D; Patel DD; Wimmer E
    Virology; 2000 Aug; 273(2):248-57. PubMed ID: 10915595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus receptor CD155-targeted oncolysis of glioma.
    Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
    Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.